WP
NXTC icon

Woodline Partners’s NextCure NXTC Stock Holding History

Woodline Partners’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$294K Buy
+27,498
New +$336K ﹤0.01% 1006
2022
Q2 		– Sell
-13,470
Closed -$786K – 860
2022
Q1 		$786K Sell
13,470
-49,530
-79% -$3.1M 0.01% 490
2021
Q4 		$4.54M Buy
+63,000
New +$5.27M 0.07% 293

Other funds holding NXTC

SCM
Squadron Capital Management Westmont, Illinois $273M AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Woodline Partners's NXTC Position: Q1 2026 in Review

Woodline Partners opened a new position in NextCure (NXTC) in Q1 2026: 27,498 shares worth $294K. The stake represents ﹤0.01% of the portfolio and ranks #1006 among its holdings. This is a return to the name: Woodline Partners previously reported a position in NXTC as recently as Q1 2022.

Woodline Partners first reported a position in NXTC in Q4 2021 and has held it in 3 quarters since. The position peaked at $4.54M in Q4 2021. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

  • Woodline Partners held 27,498 shares of NextCure worth $294K as of Q1 2026.
  • NextCure was a new Woodline Partners position in Q1 2026.
  • NextCure made up ﹤0.01% of Woodline Partners's portfolio in Q1 2026, its #1006 holding.
  • Woodline Partners first reported a position in NextCure in Q4 2021 and has held it in 3 quarters since.
  • Woodline Partners's NextCure position peaked at $4.54M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.